ProShares Ultra Health Care (RXL) Covered Calls

ProShares Ultra Health Care is a leveraged exchange-traded fund that seeks daily investment results corresponding to two times (2x) the daily performance of the S&P Health Care Select Sector Index. The fund provides magnified exposure to U.S. companies within the pharmaceutical, biotechnology, healthcare equipment, and managed care industries. It utilizes swap agreements and other financial derivatives to achieve its daily leveraged investment objective for aggressive investors.

You can sell covered calls on ProShares Ultra Health Care to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for RXL (prices last updated Mon 10:05 AM ET):

Want to make money with covered calls?  Sign Up For A Free Trial

ProShares Ultra Health Care (RXL) is a geared exchange-traded fund designed to provide twice the daily long performance of the S&P Health Care Select Sector Index. The fund serves as a tactical tool for investors who maintain a bullish short-term outlook on the health care industry. By providing 2x leverage, it allows traders to amplify their exposure to the sector without the need for margin accounts or complex direct derivative trading.

Because the fund targets a multiple of the daily return of its benchmark, it is primarily intended for short-term use. The effects of daily compounding mean that over longer periods, the fund’s performance can diverge significantly from exactly twice the index return. The portfolio is built using a combination of equity securities from the underlying index and financial instruments such as total return swaps and money market vehicles to maintain its target leverage ratio.

Sector Exposure and Underlying Holdings

The fund provides concentrated exposure to the largest and most influential health care companies in the United States. Its performance is driven by a diverse mix of sub-industries, including large-cap pharmaceuticals, medical device manufacturers, and health insurance providers. Major companies that influence the fund's underlying index include industry giants like Eli Lilly, UnitedHealth Group, and Johnson & Johnson. This mix offers a balance between high-growth biotech and more stable, cash-flow-positive managed care organizations.

Competitive Landscape

The market for health care investment products includes traditional sector funds, other leveraged vehicles, and the individual stocks that dominate the space. Key competitors and related optionable instruments include:

1. Health Care Select Sector SPDR Fund: The primary non-leveraged competitor that tracks the same underlying index as this fund.
2. Direxion Daily Healthcare Bull 3X Shares: A highly aggressive competitor providing 3x daily leverage to the health care sector.
3. Vanguard Health Care ETF: A broad-market competitor offering low-cost, non-leveraged exposure to a wider range of health care stocks.
4. iShares U.S. Healthcare ETF: Another major optionable ETF that provides traditional exposure to the domestic health care sector.
5. ProShares Ultra Nasdaq Biotechnology: A related leveraged fund from the same issuer that focuses specifically on the biotechnology sub-sector.

Strategic Outlook and Market Dynamics

The strategic utility of this fund is tied to the broader trends within the medical and pharmaceutical industries. Factors such as aging global demographics, breakthroughs in genomic medicine, and shifts in healthcare policy play a critical role in the volatility of the underlying index. As a leveraged product, the fund is most effective in trending markets where low volatility allows the benefits of compounding to work in the investor's favor.

Innovation in drug discovery and the integration of artificial intelligence in medical diagnostics continue to drive investor interest in the sector. Management focuses on maintaining high liquidity and tight correlation with the daily target to ensure the fund remains a reliable vehicle for institutional and retail traders. The fund’s long-term relevance is sustained by the essential nature of health care services, which often provides a defensive floor for the sector even during periods of broader economic contraction.

Want more examples? RXI Covered Calls | RXO Covered Calls